Effect of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on cardiovascular outcomes in dialysis patients: a systematic review and meta-analysis.
Τίτλος | Effect of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on cardiovascular outcomes in dialysis patients: a systematic review and meta-analysis. |
Publication Type | Journal Article |
Year of Publication | 2023 |
Authors | Georgianos, P. I., Tziatzios G., Roumeliotis S., Vaios V., Sgouropoulou V., Tsalikakis D. G., Liakopoulos V., & Agarwal, iv R. |
Journal | Nephrol Dial Transplant |
Volume | 38 |
Issue | 1 |
Pagination | 203-211 |
Date Published | 2023 Jan 23 |
ISSN | 1460-2385 |
Λέξεις κλειδιά | Angiotensin Receptor Antagonists, Angiotensin-Converting Enzyme Inhibitors, Antihypertensive Agents, Humans, Hypertension, Renal Dialysis |
Abstract | BACKGROUND: Angiotensin-converting enzyme inhibitors (ACEIs) and/or angiotensin receptor blockers (ARBs) are recommended by guidelines as first-line antihypertensive therapies in the general population or in patients with earlier stages of kidney disease. However, the cardioprotective benefit of these agents among patients on dialysis remains uncertain. |
DOI | 10.1093/ndt/gfac253 |
Alternate Journal | Nephrol Dial Transplant |
PubMed ID | 36069890 |